XOMA Royalty (XOMA) Goodwill & Intangibles (2022 - 2026)
XOMA Royalty (XOMA) reported Goodwill & Intangibles of $43.9 million for Q1 2026, up 72.93% on a YoY basis from $25.4 million in Q1 2025, and down 1.99% sequentially from $44.8 million in Q4 2025.
XOMA Royalty (XOMA) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 5 years of Goodwill & Intangibles data on file, last reported at $43.9 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 72.93% year-over-year to $43.9 million; the trailing twelve-month figure through Mar 2026 stood at $43.9 million (up 72.93% YoY), and the FY2025 full-year result was $44.8 million, up 72.74% from the prior year.
- Goodwill & Intangibles slipped to $43.9 million in Q1 2026, from $44.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $45.4 million in Q2 2025 to a low of $14.5 million in Q3 2023.
- A 5-year average of $26.0 million and a median of $20.3 million in 2023 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles gained 0.64% in 2023 and jumped 72.93% in 2026, its largest moves.
- Tracing XOMA's Goodwill & Intangibles over 5 years: stood at $15.2 million in 2022, then increased by 0.64% to $15.2 million in 2023, then soared by 69.93% to $25.9 million in 2024, then surged by 72.74% to $44.8 million in 2025, then slipped by 1.99% to $43.9 million in 2026.
- Business Quant data shows XOMA's Goodwill & Intangibles at $43.9 million in Q1 2026, $44.8 million in Q4 2025, and $45.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.86 Mn |
| Dec 31, 2025 | 44.76 Mn |
| Jun 30, 2025 | 45.43 Mn |
| Mar 31, 2025 | 25.37 Mn |
| Dec 31, 2024 | 25.91 Mn |
| Dec 31, 2023 | 15.25 Mn |
| Sep 30, 2023 | 14.48 Mn |
| Jun 30, 2023 | 14.70 Mn |
| Mar 31, 2023 | 14.93 Mn |
| Dec 31, 2022 | 15.15 Mn |